Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Pilot Study to Determine the Efficacy of Apremilast in the Treatment of Rosacea in Patients With Both Erythematotelangiectatic Rosacea and Papulopustular Rosacea

NCT01045551 is registered in ClinicalTrials.gov with Julian M. Mackay-Wiggan as lead sponsor.

NCT NCT01045551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01045551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Pilot Study to Determine the Efficacy of Apremilast in the Treatment of Rosacea in Patients With Both Erythematotelangiectatic Rosacea and Papulopustular Rosacea
Lead sponsor
Julian M. Mackay-Wiggan
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2010
Completion date
April 30, 2014
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erythematotelangiectatic rosacea, papulopustular rosacea